Magnetic excitations of Fe_{1+y}Se_xTe_{1-x} in magnetic and superconductive phases

We have used inelastic neutron scattering and muon-spin rotation to compare the low energy magnetic excitations in single crystals of superconducting Fe1.01Se0.50Te0.50 and non-superconducting Fe1.10Se0.25Te0.75. We confirm the existence of a spin resonance in the superconducting phase of Fe1.01Se0.50Te0.50, at an energy of 7 meV and a wavevector of (1/2,1/2,0). The non-superconducting sample exhibits two incommensurate magnetic excitations at (1/2,1/2,0)\pm(0.18,-0.18,0) which rise steeply in energy, but no resonance is observed at low energies. A strongly dispersive low-energy magnetic excitation is also observed in Fe1.10Se0.25Te0.75 close to the commensurate antiferromagnetic ordering wavevector (1/2-\delta,0,1/2) where \delta \approx 0.03. The magnetic correlations in both samples are found to be quasi-two dimensional in character and persist well above the magnetic (Fe1.10Se0.25Te0.75) and superconducting (Fe1.01Se0.50Te0.50) transition temperatures.Comment: 10 pages, 4 figure

High energy X-γ ray spectrometer on the Chandrayaan-1 mission to the Moon

The Chandrayaan-1 mission to the Moon scheduled for launch in late 2007 will include a high energy X-ray spectrometer (HEX) for detection of naturally occurring emissions from the lunar surface due to radioactive decay of the 238U and 232Th series nuclides in the energy region 20-250 keV. The primary science objective is to study the transport of volatiles on the lunar surface by detection of the 46.5 keV line from radioactive 210Pb, a decay product of the gaseous 222Rn, both of which are members of the 238U decay series. Mapping of U and Th concentration over the lunar surface, particularly in the polar and U-Th rich regions will also be attempted through detection of prominent lines from the U and Th decay series in the above energy range. The low signal strengths of these emissions require a detector with high sensitivity and good energy resolution. Pixelated Cadmium-Zinc-Telluride (CZT) array detectors having these characteristics will be used in this experiment. Here we describe the science considerations that led to this experiment, anticipated flux and background (lunar continuum), the choice of detectors, the proposed payload configuration and plans for its realizatio

Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial

Background Infections acquired in hospital are an important cause of morbidity and mortality in very preterm infants. Several small trials have suggested that supplementing the enteral diet of very preterm infants with lactoferrin, an antimicrobial protein processed from cow's milk, prevents infections and associated complications. The aim of this large randomised controlled trial was to collect data to enhance the validity and applicability of the evidence from previous trials to inform practice. Methods In this randomised placebo-controlled trial, we recruited very preterm infants born before 32 weeks' gestation in 37 UK hospitals and younger than 72 h at randomisation. Exclusion criteria were presence of a severe congenital anomaly, anticipated enteral fasting for longer than 14 days, or no realistic prospect of survival. Eligible infants were randomly assigned (1:1) to receive either enteral bovine lactoferrin (150 mg/kg per day; maximum 300 mg/day; lactoferrin group) or sucrose (same dose; control group) once daily until 34 weeks' postmenstrual age. Web-based randomisation minimised for recruitment site, gestation (completed weeks), sex, and single versus multifetal pregnancy. Parents, caregivers, and outcome assessors were unaware of group assignment. The primary outcome was microbiologically confirmed or clinically suspected late-onset infection (occurring >72 h after birth), which was assessed in all participants for whom primary outcome data was available by calculating the relative risk ratio with 95% CI between the two groups. The trial is registered with the International Standard Randomised Controlled Trial Number 88261002. Findings We recruited 2203 participants between May 7, 2014, and Sept 28, 2017, of whom 1099 were assigned to the lactoferrin group and 1104 to the control group. Four infants had consent withdrawn or unconfirmed, leaving 1098 infants in the lactoferrin group and 1101 in the sucrose group. Primary outcome data for 2182 infants (1093 [99·5%] of 1098 in the lactoferrin group and 1089 [99·0] of 1101 in the control group) were available for inclusion in the modified intention-to-treat analyses. 316 (29%) of 1093 infants in the intervention group acquired a late-onset infection versus 334 (31%) of 1089 in the control group. The risk ratio adjusted for minimisation factors was 0·95 (95% CI 0·86–1·04; p=0·233). During the trial there were 16 serious adverse events for infants in the lactoferrin group and 10 for infants in the control group. Two events in the lactoferrin group (one case of blood in stool and one death after intestinal perforation) were assessed as being possibly related to the trial intervention. Interpretation Enteral supplementation with bovine lactoferrin does not reduce the risk of late-onset infection in very preterm infants. These data do not support its routine use to prevent late-onset infection and associated morbidity or mortality in very preterm infants. Funding UK National Institute for Health Research Health Technology Assessment programme (10/57/49)

Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants

<p>Abstract</p> <p>Background</p> <p>The optimal treatment regimen or protocol for managing a persistent patent ductus arteriosus (PDA) in extremely low birth weight (ELBW) infants has not been well established. This study was aimed at evaluating the failure rate of a cyclooxygenase (COX) inhibitor (COI) for PDA closure and to determine the incidence of a PDA requiring ligation in ELBW infants. We examined the clinical characteristics and risk factors that may predict the clinical consequences of failure of PDA closure by COI.</p> <p>Methods</p> <p>Medical information on 138 infants with birth weight (BW) < 1000 gm who survived for > 48 hours was retrieved. Clinical characteristics and outcomes of patients whose PDAs closed with COI were compared with those who did not close.</p> <p>Results</p> <p>Of the 138 patients, 112 survived to discharge. Eighty (71.4%) of those who survived received 1-3 courses of COI treatment for a symptomatic PDA. A total of 32 (40%) failed COI treatment and underwent PDA ligation. Multivariable logistic regression analysis suggests that the observed differences in the outcomes in infants with or without symptomatic PDA can be explained by the babies with symptomatic PDA being more immature and sicker. No significant difference was seen in the incidence of chronic lung disease (CLD) in infants whose PDA was treated medically versus those who failed medical treatment and then underwent ligation. However, after adjusting for disease severity and other known risk factors, the odds ratio of developing CLD for surviving babies with a persistent PDA compared to those whose PDA was successfully closed with 1-2 courses of COI is 3.24 (1.07-9.81; p = 0.038).</p> <p>Conclusions</p> <p>When successfully treated, PDA in ELBW infants did not contribute significantly to the adverse outcomes such as CLD, retinopathy of prematurity (ROP) and age at discharge. This suggests that it is beneficial for a hemodynamically significant PDA to be closed. The failure of a repeat course of COI to close a PDA is a major risk factor for developing CLD in ELBW infants.</p

The importance of pulmonary hypertension in the development of chronic lung disease in preterm infants

SIGLEAvailable from British Library Document Supply Centre-DSC:DXN021191 / BLDSC - British Library Document Supply CentreGBUnited Kingdo

Social networks and spatial character a study of socio-spatial transformations of open spaces in traditional neighbourhoods of Indian cities

The present paper is part of an ongoing Doctoral Research which engages in the documentation and evaluation of the mutual relationship between the tangible aspects of traditional Indian cities and the socio-spatial aspects of living processes therein. It explores the physical transformations in terms of enclosures, edges, movement systems, visual qualities, other physical and spatial aspects of an urban space affecting the social interactions within the city, with its perceptual aspects of urban spaces within the proposed research domain and examines the quality of human behaviour. Eventually, focuses on intervention strategies of regeneration of open spaces in the core by striking a balance between the acts of preservation of the image and a development agenda which augments living conditions that generate a cohesive and integrated humane community. (Human-centric, heritage sensitive). In the course of development of the paper shall discuss how socio-spatial interactions have influenced the formation of traditional Indian cities over the history? It will look into crucial periods of urban development history, changes in social behaviour in the city and situate the study in the context of existing socio-spatial networks. It will specifically examine the role of collective spaces in the traditional old cores, which includes spaces in and around, city level artefacts, everyday open spaces - their relationship with habitants and activities in them. This will be done with examples from Indian Cities with a commentary on how such spaces have evolved with time at varied urban scales (urban area, urban block, unit level) illustrating how these enclosures and edges conditions are considered to be the major influencing factors, with which the socio-spatial aspects potentially interact. (Palaiologou & Vaughan, 2012). Cases from India will be presented to show: evolved spatial patterns, typologies and forces that shape open spaces and built form, transforming public-private interfaces and changing neighbourhood profiles leading to deserted communities in the present-day context in core cities. Finally leading to, a quest to present the city as a living organism, will examine design and planning frameworks and guidelines to evolve 'humane urban space.

Changes in pulmonary arterial pressure in preterm infants with chronic lung disease

BACKGROUND—Pulmonary arterial pressure (PAP) is raised in preterm infants with respiratory distress syndrome who subsequently develop chronic lung disease. The natural history of pulmonary hypertension in infants with chronic lung disease is unknown.
OBJECTIVES—To investigate changes in PAP, assessed non-invasively using Doppler echocardiography, in infants with chronic lung disease during the 1st year of life.
METHODS—Serial examinations were performed in infants with chronic lung disease and healthy preterm infants. The Doppler derived acceleration time to right ventricular ejection time ratio (AT/RVET) was calculated from measurements made from the pulmonary artery velocity waveform.
RESULTS—A total of 248 examinations were performed in 54 infants with chronic lung disease and 44 healthy preterm infants. The median AT/RVET was significantly lower in infants with chronic lung disease than in healthy preterm infants (0.31 v 0.37). AT/RVET significantly correlated with age corrected for prematurity in both infants with chronic lung disease (r = 0.67) and healthy infants (r = 0.55). There was no significant difference between the rate of change in AT/RVET between the two groups. In infants with chronic lung disease, multivariate analysis showed that AT/RVET was significantly independently associated with age and inversely with duration of supplemental oxygen treatment. Median AT/RVET was significantly lower in infants with chronic lung disease until 40-52 weeks of age corrected for prematurity.
CONCLUSIONS—Although PAP falls with increasing age in both infants with chronic lung disease and healthy preterm infants, it remains persistently raised in infants with chronic lung disease until the end of the 1st year of life.